StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Relypsa (RLYP) Seeks Label Change for Veltassa
May 25, 2016 4:17 PM
Relypsa, Inc. (NASDAQ: RLYP) announced that the company has submitted a supplemental New Drug Application (sNDA) to the U.S. Food ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Hot Corp. News
Trader Talk
Next Articles
BTIG Remains Bullish on Relypsa (RLYP) Following 'Surprise' CRL for AstaZeneca's (AZN) ZS-9
May 27, 2016 8:50 AM
Relypsa Submits Supplemental New Drug Application to FDA Requesting Label Changes for Veltassa Based on Phase 1 Drug-Drug Interaction Studies
May 25, 2016 4:16 PM
.jpg)
